Pfizer says coronavirus vaccine is 95% effective, will seek emergency-use authorization

Drugmaker Pfizer and its German partner BioNTech on Wednesday revealed they would be submitting their coronavirus vaccine candidate for regulatory approval "within days," after their final analysis revealed the treatment was 95% with no major side effects.